$1.23 Billion is the total value of Perceptive Advisors's 196 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 76.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $208,506,000 | +190.2% | 3,395,236 | -9.9% | 13.46% | +170.3% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $125,398,000 | -1.4% | 2,476,272 | -11.5% | 8.09% | -8.2% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $104,463,000 | +25.5% | 14,116,644 | -7.4% | 6.74% | +16.9% |
| TSRO | Sell | TESARO INC | $68,405,000 | -28.8% | 682,415 | -40.3% | 4.42% | -33.7% |
| RTRX | Sell | RETROPHIN INC | $54,752,000 | -6.3% | 2,446,482 | -25.4% | 3.53% | -12.7% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS INC | $53,802,000 | +46.9% | 2,334,168 | +5.7% | 3.47% | +36.8% |
| VSAR | Buy | VERSARTIS INC | $49,351,000 | +57.4% | 4,028,685 | +42.1% | 3.19% | +46.6% |
| NXTM | Buy | NXSTAGE MEDICAL INC | $41,726,000 | +39.2% | 1,669,703 | +20.8% | 2.69% | +29.6% |
| XNCR | Sell | XENCOR INC | $36,643,000 | +26.2% | 1,496,229 | -2.2% | 2.36% | +17.4% |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL COMPANY | $31,482,000 | +47.6% | 1,323,324 | -0.7% | 2.03% | +37.5% |
| LBIO | Sell | LION BIOTECHNOLOGIES INC | $29,360,000 | +0.4% | 3,567,553 | -1.2% | 1.90% | -6.6% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $22,191,000 | +105.2% | 683,448 | +30.8% | 1.43% | +90.9% |
| XLRN | Sell | ACCELERON PHARMA INC | $21,348,000 | +4.2% | 589,890 | -2.2% | 1.38% | -3.0% |
| CLCD | New | COLUCID PHARMACEUTICALS INC | $21,060,000 | – | 552,030 | +100.0% | 1.36% | – |
| ACRX | Sell | ACELRX PHARMACEUTICALS INC | $21,040,000 | +30.4% | 5,408,728 | -9.8% | 1.36% | +21.5% |
| QTNT | Buy | QUOTIENT LTD | $20,893,000 | +19.9% | 2,671,794 | +18.8% | 1.35% | +11.7% |
| DBVT | Buy | DBV TECHNOLOGIES SA-SPON ADRdepository receipt | $20,464,000 | +14.8% | 563,268 | +3.0% | 1.32% | +6.9% |
| CRBP | Sell | CORBUS PHARMACEUTICALS HOLDINGS | $18,339,000 | +91.7% | 2,701,023 | -15.6% | 1.18% | +78.6% |
| RGNX | Buy | REGENXBIO INC | $17,964,000 | +104.3% | 1,282,286 | +16.7% | 1.16% | +90.2% |
| RDUS | New | RADIUS HEALTH INC | $16,957,000 | – | 313,502 | +100.0% | 1.10% | – |
| FLML | New | FLAMEL TECHNOLOGIES -SP ADRdepository receipt | $16,910,000 | – | 1,363,711 | +100.0% | 1.09% | – |
| KDMN | New | KADMON INC | $16,218,000 | – | 2,209,657 | +100.0% | 1.05% | – |
| DXCM | Buy | DEXCOM INC | $15,678,000 | +57.9% | 178,849 | +42.9% | 1.01% | +47.1% |
| AERI | New | AERIE PHARMACEUTICALS INC | $15,352,000 | – | 406,771 | +100.0% | 0.99% | – |
| ALDX | ALDEYRA THERAPEUTICS INC | $15,174,000 | +37.4% | 1,940,458 | 0.0% | 0.98% | +28.0% | |
| ARDX | New | ARDELYX INC | $13,680,000 | – | 1,057,257 | +100.0% | 0.88% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $13,662,000 | +45.3% | 460,024 | -0.9% | 0.88% | +35.3% |
| DEPO | Sell | DEPOMED INC | $13,370,000 | +14.0% | 535,000 | -10.8% | 0.86% | +6.2% |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $12,822,000 | – | 391,280 | +100.0% | 0.83% | – |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $12,717,000 | +151.9% | 1,373,284 | +72.7% | 0.82% | +134.6% |
| New | CYTOMX THERAPEUTICS, INCpreferred stock | $11,634,000 | – | 742,021 | +100.0% | 0.75% | – | |
| NERV | MINERVA NEUROSCIENCES INC | $11,440,000 | +38.2% | 810,537 | 0.0% | 0.74% | +28.6% | |
| ZYNE | Buy | ZYNERBA PHARMACEUTICALS INC | $11,339,000 | +94.9% | 868,897 | +2.3% | 0.73% | +81.6% |
| DERM | Sell | DERMIRA INC | $11,215,000 | -17.0% | 331,610 | -28.2% | 0.72% | -22.7% |
| ACRS | New | ACLARIS THERAPEUTICS INC | $11,012,000 | – | 430,000 | +100.0% | 0.71% | – |
| CLSD | Sell | CLEARSIDE BIOMEDICAL INC | $11,013,000 | +147.5% | 634,801 | -0.0% | 0.71% | +130.8% |
| EVH | Sell | EVOLENT HEALTH INC CLASS A | $10,544,000 | -37.1% | 428,284 | -50.9% | 0.68% | -41.4% |
| VBIV | New | VBI VACCINES INC | $10,490,000 | – | 3,058,433 | +100.0% | 0.68% | – |
| MYOK | Buy | MYOKARDIA INC | $10,374,000 | +66.4% | 634,894 | +26.2% | 0.67% | +55.1% |
| QURE | Sell | UNIQURE NV | $10,043,000 | +1.5% | 1,312,836 | -2.2% | 0.65% | -5.5% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $9,331,000 | -16.6% | 107,000 | -17.7% | 0.60% | -22.3% |
| ANI PHARMACEUTICALS INCnote 3.000% | $9,279,000 | +14.3% | 7,500,000 | 0.0% | 0.60% | +6.4% | ||
| CDTX | Sell | CIDARA THERAPEUTICS INC | $8,855,000 | +8.3% | 773,369 | -2.5% | 0.57% | +0.9% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $8,740,000 | +24.8% | 166,509 | -1.7% | 0.56% | +16.0% |
| FWP | Buy | FORWARD PHARMA A/S-ADRdepository receipt | $8,494,000 | +50.1% | 404,472 | +29.9% | 0.55% | +39.8% |
| PFNX | Sell | PFENEX INC | $8,412,000 | +4.6% | 939,930 | -2.2% | 0.54% | -2.7% |
| ABMD | New | ABIOMED INC | $8,138,000 | – | 63,290 | +100.0% | 0.52% | – |
| ABEO | Sell | ABEONA THERAPEUTICS INC | $8,016,000 | +92.7% | 1,336,050 | -24.2% | 0.52% | +79.5% |
| AVXS | Buy | AVEXIS INC | $7,830,000 | +13400.0% | 190,000 | +12441.3% | 0.50% | +12525.0% |
| PSDV | Sell | PSIVIDA CORP | $7,683,000 | +1.9% | 2,552,431 | -4.2% | 0.50% | -5.2% |
| ACHN | New | ACHILLION PHARMACEUTICALS | $7,527,000 | – | 929,290 | +100.0% | 0.49% | – |
| AKBA | Sell | AKEBIA THERAPEUTICS INC | $7,295,000 | +9.1% | 809,096 | -9.5% | 0.47% | +1.7% |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP SHS PUT 12 12/16/2016put | $7,180,000 | – | 16,000 | +100.0% | 0.46% | – |
| NEPT | NEPTUNE TECHNOLOGIES AND BIORESOURCES | $7,155,000 | +3.9% | 6,750,444 | 0.0% | 0.46% | -3.1% | |
| AGRX | Buy | AGILE THERAPEUTICS INC | $7,120,000 | +81.9% | 1,020,011 | +98.3% | 0.46% | +69.7% |
| AGEN | New | AGENUS INC | $6,462,000 | – | 900,000 | +100.0% | 0.42% | – |
| CSU | Sell | CAPITAL SENIOR LIVING CORP | $6,305,000 | -39.1% | 375,306 | -36.0% | 0.41% | -43.3% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS INC | $6,228,000 | – | 847,458 | +100.0% | 0.40% | – |
| CLVS | New | CLOVIS ONCOLOGY INC | $6,183,000 | – | 171,500 | +100.0% | 0.40% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $6,179,000 | +142.0% | 762,800 | +76.2% | 0.40% | +125.4% |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INC | $6,048,000 | +18.8% | 244,550 | -2.2% | 0.39% | +10.5% |
| HSGX | New | HISTOGENCIS CORP | $5,706,000 | – | 1,777,777 | +100.0% | 0.37% | – |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $5,606,000 | – | 777,669 | +100.0% | 0.36% | – |
| CASC | CASCADIAN THERAPEUTICS INC | $5,599,000 | +73.9% | 3,414,121 | 0.0% | 0.36% | +61.9% | |
| PTI | Buy | PROTEOSTASIS THERAPEUTICS INC | $5,372,000 | +77.1% | 344,550 | +37.8% | 0.35% | +65.2% |
| ADMA | New | ADMA BIOLOGICS INC | $5,327,000 | – | 734,793 | +100.0% | 0.34% | – |
| ONS | Sell | ONCOBIOLOGICS INC | $5,308,000 | +18.9% | 1,248,990 | -4.9% | 0.34% | +11.0% |
| AMRN | New | AMARIN CORP PLC-ADRdepository receipt | $5,175,000 | – | 1,622,280 | +100.0% | 0.33% | – |
| SELB | Sell | SELECTA BIOSCIENCES INC | $4,961,000 | -21.2% | 348,150 | -22.6% | 0.32% | -26.6% |
| Sell | NEURODERM LTD | $4,883,000 | +11.3% | 264,114 | -2.2% | 0.32% | +3.6% | |
| ANTH | Sell | ANTHERA PHARMACEUTICALS INC | $4,598,000 | -0.3% | 1,459,627 | -2.2% | 0.30% | -7.2% |
| CLLS | Sell | CELLECTIS ADRdepository receipt | $4,323,000 | -11.4% | 179,506 | -2.2% | 0.28% | -17.5% |
| CEMP | Buy | CEMPRA INC | $4,247,000 | +51.5% | 175,503 | +3.2% | 0.27% | +41.2% |
| AGTC | Sell | APPLIED GENETIC TECHNOLOGIES | $4,167,000 | -55.2% | 426,048 | -35.3% | 0.27% | -58.3% |
| ABEOW | ABEONA THERAPEUTICS INC-CW19warrants | $4,093,000 | +282.2% | 1,259,636 | 0.0% | 0.26% | +256.8% | |
| BGNE | New | BEIGENE LTDdepository receipt | $4,069,000 | – | 132,057 | +100.0% | 0.26% | – |
| MYL | Buy | MYLAN NV | $3,610,000 | +1571.3% | 94,711 | +1794.2% | 0.23% | +1453.3% |
| INNL | Sell | INNOCOLL HOLDINGS PLC | $3,221,000 | +14.7% | 547,792 | -2.2% | 0.21% | +6.7% |
| AVEO | AVEO PHARMACEUTICALS INC | $2,766,000 | -7.4% | 3,108,808 | 0.0% | 0.18% | -13.5% | |
| OPHT | New | OPHTHOTECH CORP CALL 80 12/16/2016call | $2,740,000 | – | 600,000 | +100.0% | 0.18% | – |
| APVO | New | APTEVO THERAPEUTICS INC | $2,530,000 | – | 988,133 | +100.0% | 0.16% | – |
| PRTO | Sell | PROTEON THERAPEUTICS INC | $2,510,000 | +13.7% | 269,005 | -2.2% | 0.16% | +5.9% |
| MGCD | Sell | MGC DIAGNOSTICS CORP | $2,275,000 | +3.7% | 329,733 | -1.9% | 0.15% | -3.3% |
| NEOS | Sell | NEOS THERAPEUTICS INC | $2,175,000 | -52.8% | 330,593 | -47.3% | 0.14% | -56.2% |
| RXDX | Sell | IGNYTA INC | $2,137,000 | -9.4% | 339,727 | -21.9% | 0.14% | -15.9% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $2,075,000 | – | 65,240 | +100.0% | 0.13% | – |
| AFMD | AFFIMED NV | $2,041,000 | +12.1% | 734,301 | 0.0% | 0.13% | +4.8% | |
| ARNI | New | ARNO THERAPEUTICS INC | $1,963,000 | – | 4,177,577 | +100.0% | 0.13% | – |
| ABT | New | ABBOTT LABORATORIES | $1,946,000 | – | 46,019 | +100.0% | 0.13% | – |
| EIGR | Buy | EIGER BIOPHARMACEUTICALS INC | $1,739,000 | -16.4% | 129,920 | +23.8% | 0.11% | -22.2% |
| CBPO | Sell | CHINA BIOLOGIC PRODUCTS INC | $1,705,000 | +14.6% | 13,695 | -2.2% | 0.11% | +6.8% |
| BIO | New | BIO RAD LABORATORIES CLASS A | $1,638,000 | – | 10,000 | +100.0% | 0.11% | – |
| MDGN | Sell | MEDGENICS INC | $1,635,000 | -1.8% | 293,460 | -2.2% | 0.11% | -7.8% |
| VCRA | New | VOCERA COMMUNICATIONS INC | $1,593,000 | – | 94,236 | +100.0% | 0.10% | – |
| VCEL | Sell | VERICEL CORP | $1,526,000 | +21.7% | 544,996 | -2.2% | 0.10% | +13.8% |
| ALQA | New | ALLIQUA BIOMEDICAL INC | $1,537,000 | – | 1,921,951 | +100.0% | 0.10% | – |
| NVRO | Sell | NEVRO CORP | $1,226,000 | -95.4% | 11,746 | -96.8% | 0.08% | -95.8% |
| NVLS | Sell | NIVALIS THERAPEUTICS INC | $994,000 | +72.9% | 122,275 | -2.2% | 0.06% | +60.0% |
| BCLI | New | BRAINSTORM CELL THERAPEUTICS | $964,000 | – | 400,000 | +100.0% | 0.06% | – |
| ATRS | New | ANTARES PHARMA INC | $912,000 | – | 0 | +100.0% | 0.06% | – |
| ONSIZ | Buy | ONCOBIOLOGICS INC*w exp 2/18/2017 | $787,000 | +289.6% | 656,382 | +41.9% | 0.05% | +264.3% |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $767,000 | -79.5% | 11,561 | -82.8% | 0.05% | -80.8% |
| LCI | LANNETT COMPANY INC | $709,000 | +11.8% | 26,670 | 0.0% | 0.05% | +4.5% | |
| SCYX | Sell | SCYNEXIS INC | $662,000 | +74.2% | 171,185 | -2.2% | 0.04% | +65.4% |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $664,000 | +28.9% | 103,585 | -2.2% | 0.04% | +19.4% |
| PAHC | PHIBRO ANIMAL HEALTH CLASS A | $660,000 | +45.7% | 24,300 | 0.0% | 0.04% | +38.7% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $625,000 | -22.0% | 372,597 | 0.0% | 0.04% | -28.6% | |
| BIIB | New | BIOGEN INC | $601,000 | – | 1,921 | +100.0% | 0.04% | – |
| HRC | New | HILL ROM HOLDINGS INC | $593,000 | – | 9,563 | +100.0% | 0.04% | – |
| IMDZ | New | IMMUNE DESIGN CORP | $589,000 | – | 77,725 | +100.0% | 0.04% | – |
| WCG | WELLCARE HEALTHCARE PLANS INC | $592,000 | +9.2% | 5,056 | 0.0% | 0.04% | 0.0% | |
| HWAY | New | HEALTHWAYS INC | $572,000 | – | 21,608 | +100.0% | 0.04% | – |
| UTHR | UNITED THERAPEUTICS INC | $561,000 | +11.5% | 4,753 | 0.0% | 0.04% | +2.9% | |
| WOOF | VCA INC | $556,000 | +3.5% | 7,940 | 0.0% | 0.04% | -2.7% | |
| INCR | New | INC RESEARCH HOLDINGS INC CLASS A | $563,000 | – | 12,636 | +100.0% | 0.04% | – |
| LH | LABORATORY CORPORATION OF AMERICA HOLDINGS | $549,000 | +5.6% | 3,990 | 0.0% | 0.04% | -2.8% | |
| ABC | AMERISOURCEBERGEN CORP | $525,000 | +1.7% | 6,500 | 0.0% | 0.03% | -5.6% | |
| HUM | New | HUMANA INC CALL 190 04/21/2017call | $526,000 | – | 400 | +100.0% | 0.03% | – |
| INCY | New | INCYTE CORP | $530,000 | – | 5,619 | +100.0% | 0.03% | – |
| VWR | VWR CORP | $529,000 | -1.9% | 18,657 | 0.0% | 0.03% | -8.1% | |
| ICLR | New | ICON INC | $532,000 | – | 6,873 | +100.0% | 0.03% | – |
| PZRXQ | PHASERX INC | $514,000 | -39.7% | 200,000 | 0.0% | 0.03% | -44.1% | |
| MOH | Sell | MOLINA HEALTHCARE INC | $518,000 | +12.9% | 8,879 | -3.5% | 0.03% | +3.1% |
| AET | AETNA INC | $514,000 | -5.5% | 4,454 | 0.0% | 0.03% | -13.2% | |
| SCMP | SUCAMPO PHARMACEUTICALS CLASS A | $506,000 | +12.2% | 41,096 | 0.0% | 0.03% | +6.5% | |
| A | New | AGILENT TECHNOLOGIES INC | $496,000 | – | 10,540 | +100.0% | 0.03% | – |
| SGYPQ | New | SYNERGY PHARMACEUTICALS INC | $491,000 | – | 89,127 | +100.0% | 0.03% | – |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $492,000 | – | 7,344 | +100.0% | 0.03% | – |
| MCK | MCKESSON CORP | $497,000 | -10.6% | 2,979 | 0.0% | 0.03% | -17.9% | |
| CAH | CARDINAL HEALTH INC | $497,000 | -0.4% | 6,398 | 0.0% | 0.03% | -8.6% | |
| UHS | UNIVERSAL HEALTH SERVICES CLASS B | $492,000 | -8.0% | 3,989 | 0.0% | 0.03% | -13.5% | |
| AMAG | New | AMAG PHARMACEUTICALS INC | $479,000 | – | 19,524 | +100.0% | 0.03% | – |
| HCA | HCA HOLDINGS INC | $469,000 | -1.9% | 6,202 | 0.0% | 0.03% | -9.1% | |
| MGLN | MAGELLAN HEALTH INC | $471,000 | -18.4% | 8,772 | 0.0% | 0.03% | -25.0% | |
| LNTH | New | LANTHEUS HOLDINGS INC | $445,000 | – | 53,763 | +100.0% | 0.03% | – |
| AMSG | New | AMSURG CORP | $444,000 | – | 6,618 | +100.0% | 0.03% | – |
| UNH | UNITEDHEALTH GROUP INC | $452,000 | -0.9% | 3,231 | 0.0% | 0.03% | -9.4% | |
| CRL | CHARLES RIVER LABORATORIES | $457,000 | +1.1% | 5,482 | 0.0% | 0.03% | -6.5% | |
| AFAM | New | ALMOST FAMILY INC | $439,000 | – | 11,942 | +100.0% | 0.03% | – |
| KND | KINDRED HEATHCARE INC | $432,000 | -9.6% | 42,301 | 0.0% | 0.03% | -15.2% | |
| AMN | New | AMN HEALTHCARE INC | $428,000 | – | 13,445 | +100.0% | 0.03% | – |
| ACST | ACASTI PHARMA INC | $414,000 | +23.2% | 236,559 | 0.0% | 0.03% | +17.4% | |
| ANTM | New | ANTHEM INC | $426,000 | – | 3,400 | +100.0% | 0.03% | – |
| Q | New | QUINTILES IMS HOLDINGS INC | $414,000 | – | 5,103 | +100.0% | 0.03% | – |
| FCAU | FIAT CHRYSLER AUTOMOBILES NV | $397,000 | +4.7% | 62,000 | 0.0% | 0.03% | 0.0% | |
| THC | TENET HEALTHCARE CORP | $367,000 | -18.1% | 16,200 | 0.0% | 0.02% | -22.6% | |
| ENZ | ENZO BIOCHEM INC | $342,000 | -14.7% | 67,113 | 0.0% | 0.02% | -21.4% | |
| RACE | FERRARI NV | $322,000 | +26.8% | 6,200 | 0.0% | 0.02% | +16.7% | |
| MACK | Sell | MERRIMACK PHARMACEUTICALS INC | $311,000 | +15.2% | 48,910 | -2.2% | 0.02% | +5.3% |
| ONSIW | Buy | ONCOBIOLOGICS INC*w exp 2/18/2017 | $313,000 | +47.6% | 656,382 | +41.9% | 0.02% | +33.3% |
| MNKKQ | New | MALLINCKRODT PLC | $314,000 | – | 4,500 | +100.0% | 0.02% | – |
| ACHI | New | ACCRETIVE HEALTH INC | $305,000 | – | 125,000 | +100.0% | 0.02% | – |
| PERNIX THERAPEUTICS HLDINGS INCdbcv 4.25% 4/01/2021 | $292,000 | +46.0% | 1,000,000 | 0.0% | 0.02% | +35.7% | ||
| TDOC | New | TELADOC INC | $275,000 | – | 15,000 | +100.0% | 0.02% | – |
| GNVC | Sell | GENVEC INC | $259,000 | -92.5% | 561,320 | -7.5% | 0.02% | -92.9% |
| BVX | New | BOVIE MEDICAL CORP | $253,000 | – | 48,544 | +100.0% | 0.02% | – |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $250,000 | -21.9% | 14,673 | -2.2% | 0.02% | -27.3% |
| LLY | New | ELI LILLY & CO CALL 90 01/20/2017call | $250,000 | – | 1,000 | +100.0% | 0.02% | – |
| PMD | New | PSYCHEMEDICS CORP | $250,000 | – | 12,626 | +100.0% | 0.02% | – |
| ZGNX | New | ZOGENIX INC | $212,000 | – | 18,541 | +100.0% | 0.01% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $210,000 | – | 10,518 | +100.0% | 0.01% | – |
| GKOS | Buy | GLAUKOS CORP | $200,000 | +2122.2% | 5,300 | +1666.7% | 0.01% | +1200.0% |
| CGNT | Sell | COGENTIX MEDICAL INC | $180,000 | -63.9% | 99,008 | -80.9% | 0.01% | -65.7% |
| AMRI | New | ALBANY MOLECULAR RESEARCH | $170,000 | – | 10,300 | +100.0% | 0.01% | – |
| MTD | New | METTLER TOLEDO INTERNATIONAL | $174,000 | – | 415 | +100.0% | 0.01% | – |
| NUVA | New | NUVASIVE INC | $173,000 | – | 2,589 | +100.0% | 0.01% | – |
| ARAY | New | ACCURAY INC | $174,000 | – | 27,300 | +100.0% | 0.01% | – |
| LHCG | New | LHC GROUP INC | $175,000 | – | 4,745 | +100.0% | 0.01% | – |
| MDSO | New | MEDIDATA SOLUTIONS INC | $160,000 | – | 2,865 | +100.0% | 0.01% | – |
| BOLD | New | AUDENTES THERAPEUTICS INC | $134,000 | – | 7,500 | +100.0% | 0.01% | – |
| IVC | New | INVACARE CORP | $147,000 | – | 13,200 | +100.0% | 0.01% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $145,000 | – | 200 | +100.0% | 0.01% | – |
| DRAD | DIGIRAD CORP | $127,000 | -1.6% | 24,988 | 0.0% | 0.01% | -11.1% | |
| ATRC | New | ATRICURE INC | $126,000 | – | 7,949 | +100.0% | 0.01% | – |
| HNGR | New | HANGER INC | $128,000 | – | 15,038 | +100.0% | 0.01% | – |
| ACETQ | New | ACETO CORP | $115,000 | – | 6,054 | +100.0% | 0.01% | – |
| STML | Sell | STEMLINE THERAPEUTICS INC | $116,000 | -78.2% | 10,702 | -86.4% | 0.01% | -81.1% |
| CYNO | New | CYNOSURE INC CLASS A | $92,000 | – | 1,800 | +100.0% | 0.01% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $23,000 | – | 250 | +100.0% | 0.00% | – |
| IMMU | Sell | IMMUNOMEDICS INC | $17,000 | -96.7% | 5,343 | -97.6% | 0.00% | -97.2% |
| PPHM | Sell | PEREGRINE PHARMACEUTICALS | $10,000 | -87.7% | 24,332 | -89.2% | 0.00% | -83.3% |
| DSCI | Sell | DERMA SCIENCES INC | $14,000 | -99.2% | 2,970 | -99.3% | 0.00% | -99.2% |
| CAPR | CAPRICOR THERAPEUTICS INC | $13,000 | -18.8% | 4,000 | 0.0% | 0.00% | 0.0% | |
| SEVION THERAPEUTICS INC | $10,000 | -16.7% | 59,220 | 0.0% | 0.00% | 0.0% | ||
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -650 | -100.0% | 0.00% | – |
| AVGR | New | AVINGER INC | $5,000 | – | 1,062 | +100.0% | 0.00% | – |
| TNGNQ | TENGION INC | $1,000 | 0.0% | 1,826,399 | 0.0% | 0.00% | – | |
| SGMO | New | SANGAMO BIOSCIENCES INC | $1,000 | – | 272 | +100.0% | 0.00% | – |
| CRY | New | CRYOLIFE INC | $2,000 | – | 123 | +100.0% | 0.00% | – |
| INGN | INOGEN INC | $7,000 | +16.7% | 125 | 0.0% | 0.00% | – | |
| EGRX | Buy | EAGLE PHARMACEUTICALS INC | $3,000 | -100.0% | 544,770 | +81.6% | 0.00% | -100.0% |
| FLKS | FLEX PHARMA INC | $3,000 | +50.0% | 237 | 0.0% | 0.00% | – | |
| MD | New | MEDNAX INC | $2,000 | – | 29 | +100.0% | 0.00% | – |
| NPCUF | ALLON THERAPEUTICS INC | $0 | – | 751,124 | 0.0% | 0.00% | – | |
| ZIOP | Exit | ZIOPHARM ONCOLOGY INC | $0 | – | -1,000 | -100.0% | 0.00% | – |
| Exit | AVINGER INC | $0 | – | -1,062 | -100.0% | -0.00% | – | |
| BTX | Exit | BIOTIME INC | $0 | – | -13,740 | -100.0% | -0.00% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -2,499 | -100.0% | -0.00% | – |
| MCRB | Exit | SERES THERAPEUTICS INC | $0 | – | -1,540 | -100.0% | -0.00% | – |
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -1,113 | -100.0% | -0.00% | – |
| CORT | Exit | CORCEPT THERAPEUTICS INC | $0 | – | -11,000 | -100.0% | -0.00% | – |
| Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -2,500 | -100.0% | -0.00% | – | |
| ABBV | Exit | ABBVIE INC | $0 | – | -1,250 | -100.0% | -0.01% | – |
| DPLO | Exit | DIPLOMAT PHARMACY INC | $0 | – | -2,175 | -100.0% | -0.01% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -25,745 | -100.0% | -0.01% | – |
| HLF | Exit | HERBALIFE LTD | $0 | – | -1,250 | -100.0% | -0.01% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -6,448 | -100.0% | -0.01% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -17,313 | -100.0% | -0.01% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -2,638 | -100.0% | -0.01% | – |
| Exit | ABBOTT LABS | $0 | – | -3,040 | -100.0% | -0.01% | – | |
| NVAX | Exit | NOVAVAX INC | $0 | – | -32,000 | -100.0% | -0.02% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -71,124 | -100.0% | -0.02% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -4,948 | -100.0% | -0.02% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -8,145 | -100.0% | -0.03% | – |
| Exit | ANTHEM INC | $0 | – | -3,400 | -100.0% | -0.03% | – | |
| Exit | ALMOST FAMILY INC | $0 | – | -11,942 | -100.0% | -0.04% | – | |
| Exit | AMN HEALTHCARE SERVICES INC | $0 | – | -13,445 | -100.0% | -0.04% | – | |
| LXRX | Exit | Lexicon Pharmaceuticals Inc | $0 | – | -50,000 | -100.0% | -0.05% | – |
| LPCN | Exit | LIPOCINE INCput | $0 | – | -284,400 | -100.0% | -0.06% | – |
| LPCN | Exit | LIPOCINE INCcall | $0 | – | -300,000 | -100.0% | -0.06% | – |
| BCLI | Exit | BRAINSTROM CELL THERAPEUTICS | $0 | – | -400,000 | -100.0% | -0.07% | – |
| Exit | ARNO THERAPEUTIC INC | $0 | – | -3,463,292 | -100.0% | -0.08% | – | |
| GMED | Exit | GLOBUS MED INCcl a | $0 | – | -50,000 | -100.0% | -0.08% | – |
| Exit | ABIOMED INC | $0 | – | -14,700 | -100.0% | -0.11% | – | |
| PETX | Exit | ARATANA THERAPEUTICS INC | $0 | – | -256,500 | -100.0% | -0.11% | – |
| RLYP | Exit | RELYPSA INCput | $0 | – | -100,000 | -100.0% | -0.13% | – |
| PGNX | Exit | PROGENICS PHARMACEUTICALSput | $0 | – | -500,000 | -100.0% | -0.15% | – |
| Exit | ALLIQUA BIOMEDICAL INC | $0 | – | -1,921,951 | -100.0% | -0.15% | – | |
| IONS | Exit | Ionis Pharmaceuticals Ord Shsput | $0 | – | -100,000 | -100.0% | -0.16% | – |
| Exit | ADMA BIOLOGICS INC | $0 | – | -398,394 | -100.0% | -0.16% | – | |
| Exit | ARDELYX INC | $0 | – | -315,955 | -100.0% | -0.19% | – | |
| TKAI | Exit | TOKAI PHARMACEUTICALS INC | $0 | – | -661,041 | -100.0% | -0.25% | – |
| TSRO | Exit | TESARO INCput | $0 | – | -50,000 | -100.0% | -0.29% | – |
| Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -795,000 | -100.0% | -0.31% | – | |
| ADHD | Exit | ALCOBRA LTD | $0 | – | -1,028,272 | -100.0% | -0.32% | – |
| Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -165,240 | -100.0% | -0.37% | – | |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -485,000 | -100.0% | -0.43% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -742,021 | -100.0% | -0.52% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -196,000 | -100.0% | -0.68% | – |
| Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -0.69% | – | |
| HEDJ | Exit | WISDOMTREE EUROPE HEDGED EQUput | $0 | – | -200,000 | -100.0% | -0.70% | – |
| VBIV | Exit | VBI VACCINES INC | $0 | – | -3,058,433 | -100.0% | -0.84% | – |
| STJ | Exit | ST JUDE MEDICAL | $0 | – | -233,000 | -100.0% | -1.26% | – |
| SRPT | Exit | Sarepta Therapeutics Inccall | $0 | – | -979,200 | -100.0% | -1.30% | – |
| CPXX | Exit | CELATOR PHARMACEUTICALS INC | $0 | – | -838,400 | -100.0% | -1.75% | – |
| XBI | Exit | STREETTRACKS SPDR BIOTEC ETFput | $0 | – | -500,000 | -100.0% | -1.88% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -760,000 | -100.0% | -3.18% | – |
| SRPT | Exit | Sarepta Therapeutics Incput | $0 | – | -7,619,300 | -100.0% | -10.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-05-01 |
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.